Editorial: Highlights in psychopathology: Mental health among young adults

Meneguzzo, Paolo; Passarotti, Alessandra M.; Kaçan, Sibel Demir

doi:10.3389/fpsyg.2023.1163957

Cited by 1 publication

(2 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Interestingly, in line with previously cited studies on the Italian population [18][19][20][21][22][23], we found no changes in AD use comparable to young adults in other age groups, supporting the hypothesis that this subgroup of individuals had needed medication to treat their psychological distress during the lockdown periods and/or after the reopening phase. This evidence supports the association between younger age and lower levels of mental health during the COVID-19 pandemic [24][25][26][27][28][29][30][31][32][33][34][35][36]. We can also speculate that the increase in the use of ADs by young adults in the ASL TO4 Regione Piemonte may be related to prescriptions for the treatment of post-COVID-19 depression.…”

Section: Discussionsupporting

confidence: 80%

“…In this respect, the association between younger age and lower levels of mental health during the COVID-19 pandemic has been documented. In particular, young adults have been found to experience high rates of loneliness, anxious and depressive symptoms, stress, and sleep disturbances [24][25][26][27][28][29][30][31][32][33][34][35][36]. Whether these changes were associated with a parallel change in AD consumption needs to be better understood.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Impact of the COVID-19 Pandemic on the Use of Antidepressants by Young Adults in the ASL TO4 Regione Piemonte (Italy)

Armando,

Baroetto Parisi,

Rolando

et al. 2024

Pharmacy

View full text Add to dashboard Cite

The association between younger age and poorer mental health during the COVID-19 pandemic has been documented. Whether these changes were associated with a change in antidepressant (AD) use is not well understood. This study aimed to estimate the impact of the COVID-19 pandemic on AD use by young adults in the ASL TO4 Regione Piemonte (Italy). The impact of the pandemic on the weekly prevalence of AD users was assessed using interrupted time-series analysis with autoregressive integrated moving average models. A total of 1071 subjects (18–22 years with ≥1 AD dispensation) were included in the study. The observed prevalence was lower than the predicted value for several weeks after the introduction of the lockdown. However, it was consistently higher than the predicted values from week 134. The maximum difference between observed and predicted values (25 subjects per 10,000 young adults) was found at week 170. Changes in AD use were observed in both genders and were more pronounced for selective serotonin reuptake inhibitors. In conclusion, the impact of the COVID-19 pandemic on the mental health of young adults is likely to be significant in the coming years, which may place a future burden on pharmaceutical public health and community health.

show abstract